Back to Journals » Drug Design, Development and Therapy » Volume 5

Original Research

Five-day regimen of intramuscular or subcutaneous self-administered adrenocorticotropic hormone gel for acute exacerbations of multiple sclerosis: a prospective, randomized, open-label pilot trial

       
Total article views   HTML views PDF downloads Totals
19,901 Dovepress* 16,367+ 2,445 18,812
PubMed Central* 3,534 777 4,311
Totals 19,901 3,222 23,123
*Since 11 July 2011
+Since July 2016

View citations on PubMed Central and Google Scholar